Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter 24-Week And 52-Week Study Assessing The Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes

NCT01960179 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01960179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter 24-Week And 52-Week Study Assessing The Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
March 31, 2015
Enrollment
361 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus